GSKCH (GlaxoSmithKline Consumer Healthcare) listed in PSX,ALLSHR. GSKCH share price / stock price today is 120.23 PKR. Today volume traded in GSKCH is 8.5 K, price change is -3.13%, high price is 124.25 PKR, and low price is 120.00 PKR.
Return (%) | Absolute Return | ||||||
---|---|---|---|---|---|---|---|
1 Week | 1 Month | 3 Month | 6 Month | 1 Year | |||
Return | 0% | 0% | 0% | 0% | 0% |
Date | Announce Title | Attachments |
---|---|---|
2023-01-06 | Approval of Company Name Change - Haleon Pakistan Limited | View PDF |
2022-12-05 | Results of the Board of Directors Meeting Other than Financial Results | View PDF |
2022-12-05 | CTC of Special Resolutions Passed in the Extraordinary General Meeting 2022 | View PDF |
2022-11-25 | Notice of Board Meeting Other Than Financial Results | View PDF |
2022-11-14 | Notice of Extraordinary General Meeting - 2022 | View PDF |
2022-11-11 | Prior Publication of Extraordinary General Meeting Notice - 2022 | View PDF |
2022-11-10 | Material Information - Appointment of Non-Executive Director | View PDF |
2022-11-04 | Lifting of Force Majeure - Panadol Tablets, Panadol Extra Tablets and Children s Panadol Liquid Range | View PDF |
2022-11-02 | Notice of Corporate Briefing Session 2022 - Revised Date | View PDF |
2022-10-27 | Notice of Corporate Briefing Session - 2022 | View PDF |
2022-10-27 | Transmission of Quarterly Report for the Period Ended 30 September 2022 | View PDF |
2022-10-21 | Force Majeure - Panadol Tablets, Panadol Extra Tablets and Children s Panadol Liquid Range | View PDF |
2022-10-21 | Financial Results for the Quarter Ended 30 September 2022 | View PDF |
2022-10-13 | Notice of Board of Directors Meeting - (Q3-2022) | View PDF |
2022-09-16 | Panadol - Material Information | View PDF |
2022-08-29 | Transmission of Half Yearly Report for the Period Ended 30 June 2022 | View PDF |
2022-08-24 | Notice of Update in Email Address for Shareholders | View PDF |
2022-08-23 | BoD Approval of Change of Company Name | View PDF |
2022-08-23 | Financial Results for the Quarter Ended 30 June 2022 | View PDF |
2022-08-15 | Notice of Board of Directors Meeting - (Q2-2022) | View PDF |
2022-07-29 | Demerger of Haleon plc and Change in Ultimate Parent of the Company | View PDF |
2022-06-22 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View PDF |
2022-06-16 | Notice of Change in Email Address for Shareholders | View PDF |
2022-06-15 | Reminder for Mandatory Conversion of Physical Shares to Book-Entry Form | View PDF |
2022-06-14 | Change in Registered Office Address | View PDF |
2022-06-14 | Prior Publication of Conversion of Physical Shares to Book Entry Form | View PDF |
2022-05-20 | Material Information | View PDF |
2022-04-27 | Transmission of Quarterly Report for the Period Ended 31 March 2022 | View PDF |
2022-04-25 | Financial Results for the Quarter Ended 31 March 2022 | View PDF |
2022-04-22 | Board Meeting in Progress | View PDF |
2022-03-31 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View PDF |
2022-03-14 | Notice of Election of Directors | View PDF |
2022-03-11 | Prior Publication of Notice of Election of Directors | View PDF |
2022-02-28 | Notice of Annual General Meeting - 2021 | View PDF |
2022-02-28 | Transmission of the Annual Report for the Year Ended 2021 | View PDF |
2022-02-25 | Prior Publication of AGM Notice for the year 2021 | View PDF |
2022-02-09 | Financial Results for the Year Ended 31 December 2021 | View PDF |
2022-02-03 | Board of Directors Meeting - (Q4-2021) | View PDF |
2022-02-02 | 23rd Board of Directors Meeting REVOKED | View PDF |
2022-02-02 | 23rd Board of Directors Meeting | View PDF |
2021-12-24 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View PDF |
2021-11-11 | Notice of Corporate Briefing Session 2021 | View PDF |
2021-10-29 | Transmission of Quarterly Report for the Period Ended 30 September 2021 | View PDF |
2021-10-26 | Financial Results for the Quarter Ended 30 September 2021 | View PDF |
2021-10-15 | Notice of Board Meeting (Q3-2021) | View PDF |
2021-09-15 | Mandatory Conversion of Physical Shares to Book-Entry Form | View PDF |
2021-09-08 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations REVOKED | View PDF |
2021-09-08 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View PDF |
2021-09-08 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View PDF |
2021-08-27 | Transmission of Half-Yearly Report for the Period Ended 30 June 2021 | View PDF |
2021-08-24 | Financial Result for the Quarter Ended 2021-06-30 | View PDF |
2021-08-13 | Notice of Board Meeting (Q2-2021) | View PDF |
2021-05-05 | Credit of Final Cash Dividend - YE 31 Dec 2020 | View PDF |
2021-05-04 | Prior Publication of Dividend Notice | View PDF |
2021-04-30 | GSKCH | GlaxoSmithKline Consumer Healthcare Pakistan Limited | |
2021-04-29 | Transmission of Quarterly Report for the Period Ended 31 March 2021 | View PDF |
2021-04-23 | Financial Results for the Quarter Ended 2021-03-31 | View PDF |
2021-04-22 | Resolution passed by the Shareholders in the Annual General Meeting. | View PDF |
2021-04-16 | Notice of Board Meeting (Q1-2021) | View PDF |
2021-04-01 | Change of Chief Executive Officer | View PDF |
2021-03-31 | Transmission of Annual Report for the Year Ended 2020 | View PDF |
2021-03-31 | Notice of Annual General Meeting | View PDF |
2021-03-30 | Prior Publication of AGM Notice REVOKED | View PDF |
2021-03-30 | Prior Publication of AGM Notice | View PDF |
2021-03-30 | Prior Publication of AGM Notice | View PDF |
2021-03-25 | Revised Book Closure | View PDF |
2021-03-05 | Financial Results for the Year Ended December 31, 2020 | View PDF |
2021-03-04 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View PDF |
2021-03-03 | Appointment of Non-Executive Independent Director | View PDF |
2021-03-01 | Board Meeting - Q4-2020 | View PDF |
2021-02-08 | Material Information | |
2021-02-04 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | |
2021-02-01 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | |
2021-02-01 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations REVOKED | |
2021-02-01 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations |
GlaxoSmithKline Consumer Healthcare Pakistan Limited was incorporated in Pakistan as a public unlisted company under the provisions of the repealed Companies Ordinance, 1984 (now Companies Act, 2017) on March 31, 2015 principally to effect the demerger of consumer healthcare business of GlaxoSmithKline Pakistan Limited (GSK Pakistan). The Company is a subsidiary of GlaxoSmithKline Consumer Healthcare B.V. The ultimate parent of the Company is Haleon plc. The Company is engaged in manufacturing, marketing and sale of consumer healthcare products.
Mr. Farhan Muhammad Haroon | CEO |
---|---|
Mr. M.Z. Moin Mohajir | Chairman |
Ms. Mashal Mohammad | Company Secretary |
GSKCH (GlaxoSmithKline Consumer Healthcare) listed in PSX,ALLSHR. GSKCH Share Price / Stock Price is 120.23 PKR. You can also check; Share Price History, GSKCHPayouts, Annoucements, Snapshot, Company details, Fundamentals, Technicals and much more.
Financial literacy is your key to success and a promise of a secure future in turbulent times. We offer you the right education and resources you need to achieve your financial dreams. Sarmaaya is a trusted source of research and information about Forex, Mutual Funds, and Stocks. Our widgets, tools and calculators aid in identifying potential investment opportunities and valuable insights that can help achieve your short and long-term financial goals.
© 2024 SARMAAYA.PK